←
CellChorus145 posts
CellChorus avatar

CellChorus

@CellChorus

Life exists in motion. CellChorus® provides a high-throughput platform for evaluating how individual cells move, behave and interact.

◷ Joined July 2020▧ 58 Photos and videos
CellChorus avatar
CellChorus@CellChorus·4 Nov 2024

Attending SITC 2024? Four abstracts from CellChorus and collaborators feature TIMING data! Join us to learn how dynamic single-cell analysis improves screening donors, enhancing ADCC, quantifying potency/viability, and more. cellchorus.com/news/four-abs… @sitcancer

Chuck Schumer avatar
⟳ CellChorus retweeted
Chuck Schumer@SenSchumer·28 Jan 2025

Trump’s decision to halt federal virtually all federal grants and loans is lawless, destructive, dangerous, and cruel. It is illegal. It is unconstitutional. It’s nothing less than Project 2025 by another name. Congress must act.

InnovationMap avatar
⟳ CellChorus retweeted
InnovationMap@InnoMapHou·8 Oct 2024

CellChorus announced that the company, along with The University of Houston, has been awarded up to $2.5 million in funding. houston.innovationmap.com/un…

Breakout Ventures avatar
⟳ CellChorus retweeted
Breakout Ventures@breakout_vc·5 Nov 2024

Attending #SITC24 this week?Be sure to check out the 𝒇𝒐𝒖𝒓 presentations featuring data from @CellChorus' single-cell analysis technology! cellchorus.com/news/four-abs…

CellChorus avatar
CellChorus@CellChorus·7 Oct 2024

💥 @CellChorus and @UHouston received a $2.5 million STTR fast-track award for innovations in AI/ML from the @ncats_nih_gov at @NIH. Learn more: cellchorus.com/news/cellchor… #ai #artificialIntelligence #ml #machineLearning #singleCell #singleCellAnalysis @UHEngineering

CellChorus avatar
CellChorus@CellChorus·28 Jun 2024

- TIMING measurements of cell movements during target engagement (synapse) showed that Hy-CAR-Ts maintained significantly more motility than donor-matched Nuc-CAR-T cells. Motility has been linked to strong CAR-T potency and patient response in other studies.

CellChorus avatar
CellChorus@CellChorus·28 Jun 2024

- TIMING data showed that individual Hy-CAR-T target seeking. contact dynamics, and target killing were just as robust as Nuc-CAR-T. ‍ - TIMING data showed that Hy-CAR-T were more resistant to activation-induced cell death (AICD) AICD contributes to exhaustion of CAR-T cells.

CellChorus avatar
CellChorus@CellChorus·28 Jun 2024

- Hy-CAR-T cells CAR-T from nucleofection (Nuc-CAR-T) in terms of T cell subsets, activation, and pro-inflammatory cytokine secretion. - Hy-CAR-T secreted higher levels of the anti-inflammatory cytokine IL-10, which is linked to better CAR-T function.

CellChorus avatar
CellChorus@CellChorus·28 Jun 2024

- Hydroporation yields a higher number of transfected cells compared to both nucleofection and electroporation, partly because CAR-T made with hydroporation (Hy-CAR-T) robustly grew and divided.

CellChorus avatar
CellChorus@CellChorus·28 Jun 2024

The research approach: The team compared hydroporation with nucleofection in the generation of CAR-T cells. Key findings from the research include: - Scaled-up hydroporation can process 5 x 10^8 cells in less than 10 seconds.

CellChorus avatar
CellChorus@CellChorus·28 Jun 2024

Background: Hydropore from Indee utilizes microfluidic vortex shedding to deliver small molecules, nucleic acids, proteins, and gene-editing complexes to immune cells with low impact to cell viability and function.

Y Combinator avatar
⟳ CellChorus retweeted
Y Combinator@ycombinator·10 Jun 2024

Immunotherapy is a powerful tool in fighting cancer, but not all patients respond. However, a team of cancer researchers has recently discovered a new subset of T cells with the @CELLCHORUS (S21) TIMING platform that could improve outcomes for patients: houston.innovationmap.com/ce…